Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
49 studies found for:    Friedreich's Ataxia
Show Display Options
Rank Status Study
1 Completed
Has Results
Interferon Gamma-1b in Friedreich Ataxia (FRDA)
Condition: Friedreich Ataxia
Intervention: Drug: Interferon Gamma-1b
2 Completed A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: placebo;   Drug: deferiprone
3 Recruiting Methylprednisolone Treatment of Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Methylprednisolone
4 Recruiting Rosuvastatin (Crestor) in Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Rosuvastatin
5 Completed EPI-743 in Friedreich's Ataxia Point Mutations
Condition: Friedreich's Ataxia
Intervention: Drug: EPI-743
6 Terminated Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: varenicline;   Drug: placebo
7 Completed
Has Results
Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
Condition: Friedreich's Ataxia
Intervention: Drug: Idebenone
8 Completed Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Lu AA24493;   Drug: Placebo
9 Active, not recruiting Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Interferon γ-1b;   Drug: Placebo
10 Recruiting RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
Condition: Friedreich Ataxia
Interventions: Drug: Omaveloxolone Capsules, 2.5 mg;   Drug: Omaveloxolone Capsules, 5 mg;   Drug: Omaveloxolone Capsules, 10 mg;   Drug: Placebo;   Drug: Omaveloxolone Capsules, 20 mg;   Drug: Omaveloxolone Capsules, TBD mg;   Drug: Omaveloxolone Capsules, 40 mg;   Drug: Omaveloxolone Capsules, 80 mg;   Drug: Omaveloxolone Capsules, 160 mg;   Drug: Omaveloxolone Capsules, 300 mg
11 Recruiting Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Condition: Friedreich's Ataxia
Intervention:
12 Active, not recruiting Safety, Tolerability and Efficacy of ACTIMMUNE Dose Escalation in Friedreich's Ataxia Study
Condition: Friedreich's Ataxia
Intervention: Drug: Interferon γ-1b
13 Completed A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Deferiprone oral solution 100mg/mL;   Drug: Deferiprone oral solution 100 mg/mL
14 Recruiting An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: Acetyl-L-Carnitine
15 Completed
Has Results
An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: bupropion & Citalopram;   Drug: Bupropion & Placebo;   Drug: Placebo & Citalopram;   Drug: Placebo & Placebo
16 Recruiting Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiogram (ECHO);   Procedure: Cardiac-related blood studies
17 Completed Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept
Condition: Friedreich's Ataxia
Interventions: Drug: pioglitazone;   Drug: Placebo
18 Enrolling by invitation Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention:
19 Recruiting (+) Epicatechin to Treat Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: (+)-Epicatechin
20 Completed A Study of Resveratrol as Treatment for Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Resveratrol

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.